Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,910.00
+190.00 (2.83%)
At close: Oct 1, 2026

Biodyne Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
5,7747,0285,271
Revenue Growth
-33.32%-
Gross Profit
3,5214,4682,438
Operating Income
77.13652.26-1,730
Net Income
1,223851.5910.77
Earnings Per Share
40.8928.890.37
EPS Growth
-7806.90%-

Revenue by Geography

Fiscal YearFY 2025FY 2024
Period EndingDec '25 Dec '24
Korea
997.241,177
Europe
3,1951,657
Japan
2,0351,703
Other
800.7733.95
Total
7,0285,271

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
14,75315,98120,713
Total Debt
6.3311.0412.07
Net Cash (Debt)
14,74715,97020,701
Net Cash Growth
--22.86%-
Net Cash Per Share
500.29541.77702.30

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
1,211830.26877.41
Capital Expenditures
-4,079-3,431-539.15
Free Cash Flow
-2,869-2,601338.26
Free Cash Flow Growth
---

Margins

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
60.97%63.57%46.25%
Operating Margin
1.34%9.28%-32.81%
Pretax Margin
20.79%11.83%-2.68%
Profit Margin
21.18%12.12%0.20%
FCF Margin
-49.68%-37.01%6.42%

Valuation

Fiscal YearCurrentFY 2025FY 2024
Period EndingOct '26 Dec '25 Dec '24
PE Ratio
168.99471.8444493.04
Forward PE
39.15110.44175.00
P/FCF Ratio
--1416.66
PS Ratio
35.2857.1890.91